Maplight CEO Christopher Kroeger sells USD 1.38 million common shares

MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc.

MPLT

0.00
  • Maplight Therapeutics CEO Christopher A. Kroeger disclosed sales of 49,744 voting common shares on May 4-6.
  • Sales priced between USD 27.5 and USD 29.13 per share across the transactions.
  • Direct holdings fell to 1,580,820 shares following the sales.
  • Filing also reported 101,190 shares held indirectly through a nominee trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001658918-26-000008), on May 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.